English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Type 2 Diabetes (T2D) is a growing health problem nationally and worldwide. Magnesium (Mg) is an important mineral for a wide range of metabolic reactions. Here, our primary goal was to determine the prevalence of hypomagnesemia and its relationship to glycemic control, cardiovascular markers, and T2D-related complications.    Material and methods  A cross-sectional study from September 2015 to March 2017 including patients with T2D who attended the  Diabetes Center, Taif, Saudi Arabia. Those with known hypomagnesemia,  type 1 diabetes, gestational diabetes, end-stage renal disease, and those on magnesium supplementations were excluded. Those with a serum magnesium level &lt; 0.7 mmol/L were considered to have hypomagnesemia.    Results  A total of 285 patients with a mean age of 59.4 ± 12.7 years were enrolled. The majority of patients were female, with long-standing T2D, with a mean body mass index in the obesity category, and most of them had comorbid conditions. Twenty-eight percent of the screened T2D patients had hypomagnesemia and this group were more likely to have a bachelor degree (P = 0.034), to be on metformin, statin, and Glargine insulin (all P &lt; 0.05), have worse glycemic control (P &lt; 0.05), and a higher pulse rate (P = 0.039), but were less likely to be on diet control (P = 0.034) when compared to those with a normal Mg level.    Conclusions  Almost one-third of the screened T2D patients have hypomagnesemia. Hypomagnesemia was associated with the treatment modalities, worse glycemic control, and with peripheral artery disease.

Type 2 Diabetes control and Complications and it Relation to the Serum Magnesium Level